Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase

Molecular Immunology

Volumn 42, Issue 5, 2005, Pages 581-587

  Venkatesha, Rampura T ^a   Thangam, E Berla ^a   Zaidi, Asifa K ^a   Ali, Hydar ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chemokine; Complement; Mast cells; Signal transduction

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; CD34 ANTIGEN; COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C3A; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RANTES;

ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MAST CELL; MAST CELL DEGRANULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINES, CC; COMPLEMENT C3A; COMPLEMENT C5A; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MACROPHAGE-1 ANTIGEN; MAST CELLS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RANTES; SIGNAL TRANSDUCTION;

EID: 10644221290     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2004.09.009     Document Type: Article

References (40)

1. J. Ahamed, B. Haribabu, and H. Ali Cutting edge: differential regulation of chemoattractant receptor- induced degranulation and chemokine production by receptor phosphorylation J. Immunol. 167 2001 3559 3563
2. J. Ahamed, R.T. Venkatesha, E.B. Thangam, and H. Ali C3a enhances nerve growth factor-induced NFAT activation and chemokine production in a human mast cell line HMC-1 J. Immunol. 172 2004 6961 6968
3. R. Alam, S. Stafford, P. Forsythe, R. Harrison, D. Faubion, M.A. Lett-Brown, and J.A. Grant RANTES is a chemotactic and activating factor for human eosinophils J. Immunol. 150 1993 3442 3448
4. H. Ali, J. Ahamed, C. Hernandez-Munain, J.L. Baron, M.S. Krangel, and D.D. Patel Chemokine production by G protein-coupled receptor activation in a human mast cell line: roles of extracellular signal-regulated kinase and NFAT J. Immunol. 165 2000 7215 7223
5. H. Ali, R.M. Richardson, E.D. Tomhave, R.A. DuBose, B. Haribabu, and R. Snyderman Regulation of stably transfected platelet activating factor receptor in RBL-2H3 cells Role of multiple G proteins and receptor phosphorylation J. Biol. Chem. 269 1994 24557 24563
6. R.S. Ames, Y. Li, H.M. Sarau, P. Nuthulaganti, J.J. Foley, C. Ellis, Z. Zeng, K. Su, A.J. Jurewicz, R.P. Hertzberg, D.J. Bergsma, and C. Kumar Molecular cloning and characterization of the human anaphylatoxin C3a receptor J. Biol. Chem. 271 1996 20231 20234
7. W. Bautsch, H.G. Hoymann, Q. Zhang, I. Meier-Wiedenbach, U. Raschke, R.S. Ames, B. Sohns, N. Flemme, A. Meyer Zu Vilsendorf, M. Grove, A. Klos, and J. Kohl Cutting edge: guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease: evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma J. Immunol. 165 2000 5401 5405
8. S.C. Bischoff, A.L. de Weck, and C.A. Dahinden Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a Proc. Natl. Acad. Sci. U.S.A. 87 1990 6813 6817
9. P.J. Daffern, P.H. Pfeifer, J.A. Ember, and T.E. Hugli C3a is a chemotaxin for human eosinophils but not for neutrophils I. C3a stimulation of neutrophils is secondary to eosinophil activation J. Exp. Med. 181 1995 2119 2127
10. H.G. Drexler, and R.A. MacLeod Malignant hematopoietic cell lines: in vitro models for the study of mast cell leukemia Leuk. Res. 27 2003 671 676
11. S.M. Drouin, D.B. Corry, T.J. Hollman, J. Kildsgaard, and R.A. Wetsel Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy J. Immunol. 169 2002 5926 5933
12. S.G. el-Lati, C.A. Dahinden, and M.K. Church Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells J. Invest. Dermatol. 102 1994 803 806
13. A. Erdei, M. Andrasfalvy, H. Peterfy, G. Toth, and I. Pecht Regulation of mast cell activation by complement-derived peptides Immunol. Lett. 92 2004 39 42
14. A. Erdei, and I. Pecht Complement peptides and mast cell triggering Immunol. Lett. 54 1996 109 112
15. W. Fureder, H. Agis, H. Semper, F. Keil, U. Maier, M.R. Muller, K. Czerwenka, H. Hofler, K. Lechner, and P. Valent Differential response of human basophils and mast cells to recombinant chemokines Ann. Hematol. 70 1995 251 258
16. N.P. Gerard, and C. Gerard Complement in allergy and asthma Curr. Opin. Immunol. 14 2002 705 708
17. E.P. Grant, D. Picarella, T. Burwell, T. Delaney, A. Croci, N. Avitahl, A.A. Humbles, J.C. Gutierrez-Ramos, M. Briskin, C. Gerard, and A.J. Coyle Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis J. Exp. Med. 196 2002 1461 1471
18. K. Hartmann, B.M. Henz, S. Krugerkrasagakes, J. Kohl, R. Burger, S. Guhl, I. Haase, U. Lippert, and T. Zuberbier C3a and C5a stimulate chemotaxis of human mast cells Blood 89 1997 2863 2870
19. H. Hawlisch, M. Wills-Karp, C.L. Karp, and J. Kohl The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma Mol. Immunol. 41 2004 123 131
20. S.T. Holgate, K.S. Bodey, A. Janezic, A.J. Frew, A.P. Kaplan, and L.M. Teran Release of RANTES, MIP-1 alpha and MCP-1 into asthmatic airways following endobronchial allergen challenge Am. J. Respir. Crit. Care Med. 156 1997 1377 1383
21. A.A. Humbles, B. Lu, C.A. Nilsson, C. Lilly, E. Israel, Y. Fujiwara, N.P. Gerard, and C. Gerard A role for the C3a anaphylatoxin receptor in the effector phase of asthma Nature 406 2000 998 1001
22. C.L. Karp, A. Grupe, E. Schadt, S.L. Ewart, M. Keane-Moore, P.J. Cuomo, J. Kohl, L. Wahl, D. Kuperman, S. Germer, D. Aud, G. Peltz, and M. Wills-Karp Identification of complement factor five as a susceptibility locus for experimental allergic asthma Nat. Immunol. 1 2000 221 226
23. A.S. Kirshenbaum, C. Akin, Y. Wu, M. Rottem, J.P. Goff, M.A. Beaven, V.K. Rao, and D.D. Metcalfe Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI Leuk. Res. 27 2003 677 682
24. A.S. Kirshenbaum, J.P. Goff, T. Semere, B. Foster, L.M. Scott, and D.D. Metcalfe Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+) and expresses aminopeptidase-N (CD13) Blood 94 1999 2333 2342
25. P. Langkabel, J. Zwirner, and M. Oppermann Ligand-induced phosphorylation of anaphylatoxin receptors C3aR and C5aR is mediated by G protein-coupled receptor kinases Eur. J. Immunol. 29 1999 3035 3046
26. N.W. Lukacs, A.L. Miller, and C.M. Hogaboam Chemokine receptors in asthma: searching for the correct immune targets J. Immunol. 171 2003 11 15
27. D. MacGlashan Jr., and J. Warner Stimulus-dependent leukotriene release from human basophils: a comparative study of C5a and Fmet-leu-phe J. Leukoc. Biol. 49 1991 29 40
28. M.J. Marinissen, and J.S. Gutkind G-protein-coupled receptors and signaling networks: emerging paradigms Trends Pharmacol. Sci. 22 2001 368 376
29. G. Nilsson, M. Johnell, C.H. Hammer, H.L. Tiffany, K. Nilsson, D.D. Metcalfe, A. Siegbahn, and P.M. Murphy C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway J. Immunol. 157 1996 1693 1698
30. R.A. Panettieri Jr. Airway smooth muscle: immunomodulatory cells that modulate airway remodeling? Respir. Physiol. Neurobiol. 137 2003 277 293
31. J. Rivera Molecular adapters in FcεRI signaling and the allergic response Curr. Opin. Immunol. 14 2002 688 693
32. J.M. Schuh, K. Blease, H. Bruhl, M. Mack, and C.M. Hogaboam Intrapulmonary targeting of RANTES/CCL5-responsive cells prevents chronic fungal asthma Eur. J. Immunol. 33 2003 3080 3090
33. E.S. Schulman, T.J. Post, P.M. Henson, and P.C. Giclas Differential effects of the complement peptides C5a and C5a des Arg on human basophil and lung mast cell histamine release J. Clin. Invest. 81 1988 918 923
34. B. Settmacher, C. Rheinheimer, H. Hamacher, R.S. Ames, A. Wise, L. Jenkinson, D. Bock, M. Schaefer, J. Kohl, and A. Klos Structure-function studies of the C3a-receptor: C-terminal serine and threonine residues, which influence receptor internalization and signaling Eur. J. Immunol. 33 2003 920 927
35. N. Shushakova, J. Skokowa, J. Schulman, U. Baumann, J. Zwirner, R.E. Schmidt, and J.E. Gessner C5a anaphylatoxin is a major regulator of activating versus inhibitory FcγRs in immune complex-induced lung disease J. Clin. Invest. 110 2002 1823 1830
36. A. Song, A. Patel, K. Thamatrakoln, C. Liu, D. Feng, C. Clayberger, and A.M. Krensky Functional domains and DNA binding sequences of RFLAT-1/KLF13 A Kruppel-like transcription factor of activated T lymphocytes J. Biol. Chem. 5 2002 5
37. H. Turner, and J.P. Kinet Signalling through the high-affinity IgE receptor FcεRI Nature 402 1999 B24 30
38. A. Ueda, Y. Ishigatsubo, T. Okubo, and T. Yoshimura Transcriptional regulation of the human monocyte chemoattractant protein-1 gene Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity J. Biol. Chem. 272 1997 31092 31099
39. P.A. Ward, N.C. Riedemann, R.F. Guo, M. Huber-Lang, J.V. Sarma, and F.S. Zetoune Anti-complement strategies in experimental sepsis Scand. J. Infect. Dis. 35 2003 601 603
40. M.R. Woolhiser, K. Brockow, and D.D. Metcalfe Activation of human mast cells by aggregated IgG through FcγRI: additive effects of C3a Clin. Immunol. 110 2004 172 180